Myer Holdings Limited (ASX: MYR) reported a solid top-line performance for 1H FY26, with total sales rising 24.5% to $2.28 billion, while underlying net profit after tax increased 21.7% to $51.7 million. The company also maintained a strong net cash position of $287 million, providing flexibility to support its ongoing transformation strategy.
However, beneath headline growth, underlying trends indicate pressure on profitability. On a comparable basis, earnings declined due to continued investment in strategic initiatives and a shift toward lower-margin categories. Despite record customer engagement and loyalty growth, Myer continues to navigate a challenging retail environment marked by cautious consumer spending and rising operating costs. Myer Holdings Limited (ASX: MYR) was trading at $0.287, down $0.002 or 0.86%.
Clover Gains Momentum on Margins and Product Mix
In contrast, Clover Corporation Limited (ASX: CLV) delivered a strong set of results driven by operational efficiency and improved product mix. Revenue rose to $44.1 million, while EBITDA climbed to $6.9 million. Net profit after tax also increased to $4.2 million, reflecting stronger earnings quality.
A key highlight was the expansion in gross margins to 35.6%, supported by manufacturing performance and diversification across Europe and ANZ markets. The company’s exposure to structural growth segments, including infant, adult, and senior nutrition, appears to be strengthening its long-term outlook. Clover has guided FY26 revenue between $92 million and $96 million, indicating continued growth momentum. Clover Corporation Limited (ASX: CLV) was trading at $0.885, up $0.140 or 18.79%.
Outlook: Scale vs Efficiency
The results underscore a clear divergence: Myer is leveraging scale and strategic investment to drive long-term growth, while Clover is capitalising on efficiency and niche demand to expand margins. For investors, the focus now shifts to execution—whether Myer can translate investment into sustained profitability, and whether Clover can maintain its growth trajectory amid global uncertainties.
At the time of writing, Myer Holdings Limited (ASX: MYR) was trading at $0.287, down $0.002 or 0.86% for the day, while Clover Corporation Limited (ASX: CLV) was trading at $0.885, up $0.140 or 18.79%.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
ASX Earnings Today: Did Myer and Clover Deliver Strong 1H FY26 Results?
Highlights:
Retail Stability Meets Cost Challenges
Myer Holdings Limited (ASX: MYR) reported a solid top-line performance for 1H FY26, with total sales rising 24.5% to $2.28 billion, while underlying net profit after tax increased 21.7% to $51.7 million. The company also maintained a strong net cash position of $287 million, providing flexibility to support its ongoing transformation strategy.
However, beneath headline growth, underlying trends indicate pressure on profitability. On a comparable basis, earnings declined due to continued investment in strategic initiatives and a shift toward lower-margin categories. Despite record customer engagement and loyalty growth, Myer continues to navigate a challenging retail environment marked by cautious consumer spending and rising operating costs. Myer Holdings Limited (ASX: MYR) was trading at $0.287, down $0.002 or 0.86%.
Clover Gains Momentum on Margins and Product Mix
In contrast, Clover Corporation Limited (ASX: CLV) delivered a strong set of results driven by operational efficiency and improved product mix. Revenue rose to $44.1 million, while EBITDA climbed to $6.9 million. Net profit after tax also increased to $4.2 million, reflecting stronger earnings quality.
A key highlight was the expansion in gross margins to 35.6%, supported by manufacturing performance and diversification across Europe and ANZ markets. The company’s exposure to structural growth segments, including infant, adult, and senior nutrition, appears to be strengthening its long-term outlook. Clover has guided FY26 revenue between $92 million and $96 million, indicating continued growth momentum. Clover Corporation Limited (ASX: CLV) was trading at $0.885, up $0.140 or 18.79%.
Outlook: Scale vs Efficiency
The results underscore a clear divergence: Myer is leveraging scale and strategic investment to drive long-term growth, while Clover is capitalising on efficiency and niche demand to expand margins. For investors, the focus now shifts to execution—whether Myer can translate investment into sustained profitability, and whether Clover can maintain its growth trajectory amid global uncertainties.
At the time of writing, Myer Holdings Limited (ASX: MYR) was trading at $0.287, down $0.002 or 0.86% for the day, while Clover Corporation Limited (ASX: CLV) was trading at $0.885, up $0.140 or 18.79%.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au